The EMA has doubts about the need to give booster doses "continuously"

The Public Health Commission, in which the autonomous communities and the Ministry of Health are represented, has agreed this Thursday that immunosuppressed people receive a fourth dose of the COVID-19 vaccine five months after the last dose.

“People who received additional doses of mRNA vaccine for being included in Group 7 or being people receiving treatment with immunosuppressive drugs will receive a booster dose 5 months after the last dose,” explained the Ministry of Health.

This group includes, among others, people at very high risk, such as those with cystic fibrosis, hematopoietic stem cell transplantation, solid organ transplantation and on the waiting list for solid organ transplantation, lung, kidney, pancreatic, heart transplantation, hepatic or intestinal.

Also dialysis patients of various degrees, oncohematological diseases and various types of cancer patients with or without chemotherapy, as well as various cases of HIV, immunodeficiencies or Down’s syndromes over 40 years of age.

This Thursday, the Commission has also authorized booster doses of the COVID-19 vaccine to all people over 18 years of age. Thus, the age range of vaccination with booster doses is broadened in Spain, which was at the moment up to 40 years.

In this way, once you finish with adults over 40 years of age, you will start with those of 30 and so on until reaching those of 18. In any case, priority will be given to people at risk and those who completed the longest the vaccination schedule.

On the other hand, the Commission has also approved the reduction of the interval between the full regimen and the booster dose from six to five months, “in line with what other neighboring countries are doing”.

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more